ArticleCureus2026
Comparative Outcomes of Surgical Stabilization and Nonoperative Management for Rib Fractures: A Quasi-experimental Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRib fractures are among the most common injuries in blunt thoracic trauma and are associated with significant morbidity due to respiratory compromise, pain, and pulmonary complications. While nonoperative management remains the traditional approach, surgical stabilization of rib fractures (SSRF) has gained attention for improving outcomes in patients with multiple displaced rib fractures and flail chest. This study aimed to compare the clinical and functional outcomes of SSRF vs. nonoperative management in patients with multiple rib fractures at a Level I Trauma Center in Eastern India.
methodsA quasi-experimental study was conducted from January 2023 to December 2024, including 58 patients aged 18-70 years with multiple displaced rib fractures or flail chest. Patients were divided into two groups: Group A (n = 29) underwent surgical stabilization, and Group B (n = 29) received nonoperative management. Demographic variables, clinical outcomes, duration of hospital stay, ICU stay, ventilatory days, pain scores (Visual Analog Scale), functional outcomes, inflammatory markers, and complications were recorded. Statistical analysis was performed using the Statistical Package for the Social Sciences version 25 (IBM Corp., Armonk, NY), with p < 0.05 considered statistically significant.
resultsBoth groups were comparable in demographic characteristics, injury profile, and associated thoracic injuries. Patients in the SSRF group demonstrated significantly shorter hospital stay (9.21 ± 1.99 vs. 12.10 ± 1.52 days, p = 0.01), ICU stay (2.72 ± 0.88 vs. 4.24 ± 0.83 days, p = 0.01), and ventilatory duration (3.03 ± 1.15 vs. 5.38 ± 1.24 days, p = 0.01). Postoperative pain scores were significantly lower in the operative group at all follow-up intervals (p = 0.01). Functional recovery and quality-of-life scores showed progressive improvement in the surgical group. Chronic chest pain was significantly lower in the operative group (1 (3.4%) vs. 26 (89.7%), p = 0.01), with no mortality reported in either group.
conclusionSSRF significantly improves clinical outcomes by reducing hospital stay, ICU stay, ventilatory duration, pain severity, and chronic complications compared to nonoperative management. Despite limitations such as a nonrandomized design and a modest sample size, SSRF appears to be an effective treatment strategy for selected patients with multiple rib fractures and flail chest. Further randomized studies with larger sample sizes are recommended to validate these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.